Exchange Traded Concepts, LLC Intellia Therapeutics, Inc. Transaction History

Exchange Traded Concepts, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 26, 2022	SELL	$58.27 - $118.99 $213,326 - $435,622	-3,661 Closed	0 $0
Q4 2021 Jan 13, 2022	BUY	$100.76 - $138.36 $368,882 - $506,535	3,661 New	3,661 $433,000
Q1 2021 Apr 20, 2021	SELL	$46.59 - $83.68 $256,664 - $460,993	-5,509 Closed	0 $0
Q4 2020 Jan 19, 2021	SELL	$18.83 - $63.53 $443,069 - $1.49 Million	-23,530 Reduced 81.03%	5,509 $300,000
Q3 2020 Oct 30, 2020	BUY	$17.47 - $24.93 $261,997 - $373,875	14,997 Added 106.8%	29,039 $577,000
Q2 2020 Jul 15, 2020	BUY	$11.14 - $22.87 $72,588 - $149,020	6,516 Added 86.58%	14,042 $295,000
Q1 2020 Apr 14, 2020	BUY	$9.44 - $15.58 $35,315 - $58,284	3,741 Added 98.84%	7,526 $92,000
Q4 2019 Jan 22, 2020	BUY	$10.43 - $17.67 $39,477 - $66,880	3,785 New	3,785 $56,000

313

91.5M

442K

880K

Ticker NTLA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,011,800
Market Cap $929M
Description
Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 for the treatment of hereditary angioedema, as well as other liver-focused programs comprising hemoph...

Get notified when there are updates to the investment portfolio of Exchange Traded Concepts, LLC, based on Form 13F filings with the SEC.

Stay updated on Exchange Traded Concepts, LLC with notifications on news.